coronavirus
Does COVID-19 infection raise the risk of diabetes?
Phil Taylor
coronavirus, COVID-19, Diabetes, patients
0 Comment
Pfizer makes case for fourth COVID jab dose to FDA
Phil Taylor
BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Pfizer
0 Comment
As England ends free COVID testing, company debuts £1.99 LFT
Phil Taylor
coronavirus, COVID-19, COVID-19 detection kits, diagnosis, Everything Genetic
0 Comment
COVID vaccines not linked to excess deaths, says CDC
Phil Taylor
BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Pfizer, safety, Spikevax
0 Comment
Olumiant benefits additive to other drugs in severe COVID patients
Phil Taylor
Actemra, coronavirus, COVID-19, Eli Lilly, Gilead Sciences, Incyte, JAK inhibitor, Olumiant, Roche, Veklury
0 Comment
Verily taps Oncimmune tech for ‘long COVID’ study
Phil Taylor
coronavirus, COVID-19, Long COVID, oncimmune, partnering, Verily
0 Comment
Synairgen slumps as inhaled COVID drug fails pivotal test
Phil Taylor
antiviral, coronavirus, COVID-19, interferon, respiratory, Synairgen
0 Comment
Lilly bags US okay for rival to GSK’s COVID-19 drug Xevudy
Phil Taylor
antibody, bebtelovimab, coronavirus, COVID-19, Eli Lilly, GlaxoSmithKline, xevudy
0 Comment